Vaxine Pty Ltd - Adelaide, South Australia

+61 (0)420 878 911
queries@vaxine.net

Follow

Vaxine Vaxine
Skip to content
  • Home
  • About
    • About
    • People
  • Projects
  • Publications
  • News
  • Contact

Vaxine Pty Ltd - Adelaide, South Australia

+61 (0)420 878 911
queries@vaxine.net

Follow

Attachment

logo
virus
Original size is 183 × 100 pixels
https://vaxine.net/wp-content/uploads/2022/03/cropped-logo.png

https://vaxine.net/wp-content/uploads/2022/03/cropped-logo.png

Vaxine is an Australian-based biotechnology company that over the last 20 years has developed an extensive portfolio of vaccines and immunotherapies, including vaccines against Covid-19, influenza, hepatitis B, and Japanese encephalitis plus immunotherapies against allergy and cancer.  Underlying all these successful vaccines is Vaxine’s powerful vaccine adjuvant technology plus its capabilities in applying artificial intelligence to rapid drug design.

  • About
  • People
  • Projects
  • Publications
  • News
  • Contact

News

  • Phase 2 trial results April 22, 2022
  • TGA grants Provisional Determination to Vaxine for its COVID-19 Recombinant Protein Vaccine April 1, 2022
  • Efficacy of COVID-19 vaccines (Video) September 21, 2021
Read more

© 2022 Vaxine Pty Ltd. All rights reserved.
Made with ❤ by Howdy Innovation

